ArticleWomen's health issues : official publication of the Jacobs Institute of Women's Health
Time from Screening Mammography to Biopsy and from Biopsy to Breast Cancer Treatment among Black and White, Women Medicare Beneficiaries Not Participating in a Health Maintenance Organization.
Article in Women's health issues : official publication of the Jacobs Institute of Women's Health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Rural-urban disparities in cardiovascular and other competing risk of death among cancer patients.Journal of advanced research · 2026Article
- Prospective deployment of AI-based risk stratification to enable expedited mammography workflow in a safety-net setting.NPJ digital medicine · 2026Article
- Burden and trajectory of social needs after breast cancer diagnosis at a safety-net hospital.Breast cancer research and treatment · 2024Article
- Understanding mechanisms of racial disparities in breast cancer: an assessment of screening and regular care in the Carolina Breast Cancer Study.Cancer causes & control : CCC · 2024Article
- Fungal Infections and Social Determinants of Health: Using Data to Identify Disparities.Current fungal infection reports · 2024Article
- Disparities in Breast Cancer Care-How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity.Healthcare (Basel, Switzerland) · 2024Review
- Racial/ethnic disparities in the association between patient care experiences and receipt of initial surgical breast cancer care: findings from SEER-CAHPS.Breast cancer research and treatment · 2024Article
- Latent pathway-based Bayesian models to identify intervenable factors of racial disparities in breast cancer stage at diagnosis.Cancer causes & control : CCC · 2024Article
- Social determinants of health and health inequities in breast cancer screening: a scoping review.Frontiers in public health · 2024Article
- Differential response to neoadjuvant endocrine therapy for Black/African American and White women in NCDB.Breast cancer research and treatment · 2024Article
- The Current State of Timeliness in the Breast Cancer Diagnosis Journey: Abnormal Screening to Biopsy.Seminars in ultrasound, CT, and MR · 2023Review
- Addressing Disparities Related to Access of Multimodality Breast Imaging Services Before and During the COVID-19 Pandemic.Academic radiology · 2022Review
- Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients.Journal of general internal medicine · 2022Article
- Mobile Mammography Services and Underserved Women.Diagnostics (Basel, Switzerland) · 2022Review
- Naïve Bayesian network-based contribution analysis of tumor biology and healthcare factors to racial disparity in breast cancer stage-at-diagnosis.Health information science and systems · 2021Article
- Article
- Beyond Black and White: race and sexual identity as contributors to healthcare system distrust after breast cancer screening among US women.Psycho-oncology · 2021Article
- Observational
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThere is a breast cancer mortality gap adversely affecting Black women in the United States. This study assessed the relationship between number of days between abnormal mammogram, biopsy, and treatment among Medicare (Part B) beneficiaries ages 65 to 74 and 75 to 84 years, accounting for race and comorbidity.
methodsA cohort of non-Hispanic Black and non-Hispanic White women residing in the continental United States and receiving no services from a health maintenance organization was randomly selected from the Center for Medicare and Medicaid Services denominator file. The cohort was followed from 2005 to 2008 using Center for Medicare and Medicaid Services claims data. The sample included 4,476 women (weighted n = 70,731) with a diagnosis of breast cancer. Cox proportional hazard modeling was used to identify predictors of waiting times.
findingsBlack women had a mean of 16.7 more days between biopsy and treatment (p < .001) and 15.7 more days from mammogram to treatment (p = .003) than White women. Median duration from abnormal mammogram to treatment exceeded National Quality Measures for Breast Centers medians regardless of race, age, or number of comorbidities (overall 43 days vs. the National Quality Measures for Breast Centers value of 28 days).
conclusionsMedical care delays may contribute, in part, to the widening breast cancer mortality gap between Black women and White women. Further study, with additional clinical and social information, is needed to broaden scientific understanding of racial determinants and assess the clinical significance of mammogram to treatment times among Medicare beneficiaries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.